Research news

Search news

Browse by category

Browse: ▾

Select all - Clear all

Cochrane Review highlights the need for new interventions to improve chronic obstructive pulmonary disease in primary care

A new Monash randomised controlled trial called ‘TERRACOTTA’ will set out to address deficiencies in Australia’s primary care relating to COPD management.
Medicine & health

Volunteers safely administered first dose in clinical trial of Melbourne-made COVID-19 vaccines

The two vaccine candidates were created by researchers at the Doherty Institute and MIPS and are distinct from existing vaccines in use around the globe.
Medicine & health

MIPS researcher founding scientist of new biotech company launched with AUD$10m investment

Ankere Therapeutics is dedicated to the development of new therapies that target inflammatory diseases, particularly those affecting the lung.
Industry & partnerships

Trial dedicated to repurposed therapies for COVID-19 wins prestigious international award

Monash University Adjunct Research Professor and Distinguished Alumnus, Craig Rayner, is part of the international team behind the TOGETHER trial, which has been awarded the David Sackett Trial of the Year for 2021.
Medicine & health

New Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications Released for Public Consultation

Development of the Guidelines were led by Centre for Medicine Use and Safety, with funding from the National Health and Medical Research Council Dementia Centre for Research Collaboration in response to recommendations from the recent Royal
Medicine & health

Monash pharmacy degree wins AACP Innovation award

The team of educators behind Australia’s first integrated bachelor and master of pharmacy has been awarded the 2022 Innovation in Teaching and Assessment award by the prestigious American Association of Colleges and Pharmacy.
Learning & teaching

Monash study uses drug delivery platform that mimics dietary lipid to enhance absorption of widely used opioid replacement therapy

Monash University researchers have harnessed a new drug delivery technology to allow the oral administration of buprenorphine (BUP), a drug used for severe pain management and opioid replacement therapy. At present BUP cannot be administered in a
Medicine & health

Monash University the world’s #1 for Pharmacy and Pharmacology in QS rankings

Monash University has ranked number one globally in the 2022 QS World University Rankings by Subject for Pharmacy and Pharmacology for the first time, making it Australia’s top-performing university.
University news

CDCO to share in $17 million of VHESIF funding

The CDCO will receive funding to support the purchase of an Acoustic Ejection Mass Spectrometer - a state-of-the-art instrument designed to greatly expedite bioanalytical processing and increase throughput for pharmaceutical profiling of new drug
University news